Table 1.

Patient characteristics (n = 138)

P
Median age, y (range)59 (36–87)
Median observation time of patients alive, mo (range)41 (8–137)
FIGO stage, n (%)
    III94 (68.1)0.015
    IV44 (31.9)
Disease, n (%)
    Ovarian cancer114 (82.6)0.053
    Primary peritoneal cancer24 (17.4)
Histologic subtype, n (%)
    Serous papillary adenocarcinoma114 (82.6)0.075
    Endometroid adenocarcinoma11 (8.0)
    Clear cell carcinoma10 (7.2)
    Mucinous carcinoma3 (2.2)
Histologic grade, n (%)
    G1 + G242 (30.4)0.878
    G396 (69.6)
Residual tumor (cm), n (%)
    ≤172 (52.2)0.001
    >162 (44.9)
    Unknown4 (2.9)
Chemotherapy, n (%)
    Taxane/platinum115 (83.3)0.002
    Platinum only3 (2.2)
    Other/platinum13 (9.4)
    None7 (5.1)
Chemotherapy type, n (%)
    Neoadjuvant22 (15.9)0.338
    Primary109 (79.0)
    None7 (5.1)
  • NOTE: P values were calculated with the log-rank tests to determine if the clinicopathologic factors are predictors of overall survival.